User:Korey Griffin: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 13: Line 13:


I seek to create new ways for bench scientists to optimize their protocols so that results are more purposeful toward producing publication quality data. Researcher time and labor at the bench is very important to consider when running experiments over time. I am joining OWW in order to contribute research antibody (immunoglobulin) and siRNA/shRNA related protocols in order to facilitate the research experience. When I am not at pondering the nuances of protocol optimization (check useful links below, ie [http://openwetware.org/wiki/Griffin:Western_Blot_Optimization Western Blot Optimization]), I enjoy surfing, mt. biking, camping, and pen&ink artwork.
I seek to create new ways for bench scientists to optimize their protocols so that results are more purposeful toward producing publication quality data. Researcher time and labor at the bench is very important to consider when running experiments over time. I am joining OWW in order to contribute research antibody (immunoglobulin) and siRNA/shRNA related protocols in order to facilitate the research experience. When I am not at pondering the nuances of protocol optimization (check useful links below, ie [http://openwetware.org/wiki/Griffin:Western_Blot_Optimization Western Blot Optimization]), I enjoy surfing, mt. biking, camping, and pen&ink artwork.
Value your time, know the reagents & have confidence in your technique.


I wish you success!
I wish you success!

Revision as of 14:28, 18 September 2008

Contact Info

Pondering the nuances of protocol optimization
  • Korey Griffin
  • Santa Cruz Biotechnology, Inc.
  • 2145 Delaware Avenue Santa Cruz, CA 95060
  • Santa Cruz, California, USA
  • Email me through OpenWetWare

I am a technical support representative for Santa Cruz Biotechnology, Inc. My primary focus is building relationships with industry and academic institutions for anyone from graduate students to post-doctoral researchers alike, who are running new experiments for the first time or trying out new antibodies.

Experienced technicians in all aspects of research become so skilled at bench techniques that the nuances of these procedures become second nature, and often times the nuances are what influence the quality and consistency of obtaining good data over time.

I seek to create new ways for bench scientists to optimize their protocols so that results are more purposeful toward producing publication quality data. Researcher time and labor at the bench is very important to consider when running experiments over time. I am joining OWW in order to contribute research antibody (immunoglobulin) and siRNA/shRNA related protocols in order to facilitate the research experience. When I am not at pondering the nuances of protocol optimization (check useful links below, ie Western Blot Optimization), I enjoy surfing, mt. biking, camping, and pen&ink artwork.

I wish you success!

Education

  • 2000, MS Biochemistry, University of Missouri-Columbia

Advisor: Gary Weisman Ph.D.

  • 1997, BS, University of Missouri-Columbia

Research interests

  1. Helping scientists succeed with the products I represent
  2. Antibody protocol optimization and imaging
  3. siRNA & shRNA design & experimental methodology
  4. Antibody design & experimental methodology

Publications

  1. Liu J, Liao Z, Camden J, Griffin KD, Garrad RC, Santiago-Pérez LI, González FA, Seye CI, Weisman GA, and Erb L. Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem. 2004 Feb 27;279(9):8212-8. DOI:10.1074/jbc.M312230200 | PubMed ID:14670955 | HubMed [Paper1]
  2. Erb L, Liu J, Ockerhausen J, Kong Q, Garrad RC, Griffin K, Neal C, Krugh B, Santiago-Pérez LI, González FA, Gresham HD, Turner JT, and Weisman GA. An RGD sequence in the P2Y(2) receptor interacts with alpha(V)beta(3) integrins and is required for G(o)-mediated signal transduction. J Cell Biol. 2001 Apr 30;153(3):491-501. DOI:10.1083/jcb.153.3.491 | PubMed ID:11331301 | HubMed [Paper2]

All Medline abstracts: PubMed | HubMed

Useful links